 |
|
Variations in Hypertension Control in Indigent Rural Primary Care Clinics in North Carolina
Adam O. Goldstein, MD;
Timothy S. Carey, MD, MPH;
Denise Levis, RN, MPH;
Susan Madson, RN, BSN;
James Bernstein, MHA
Arch Fam Med. 1994;3(6):514-519.
References
Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.
1. Dustan HP, Caplan LR, Curry CL, et al. Report of the American Heart Association Task Force on the availability of cardiovascular drugs to the medically indigent. Circulation. 1992;85:849-860.
FREE FULL TEXT
2. Alderman MH. Which antihypertensive drugs first—and why! JAMA. 1992;267:2786-2787.
FREE FULL TEXT
3. Stason WB. Opportunities to improve the cost-effectiveness of treatment for hypertension. Hypertension. 1991;18(suppl_1):161-166.
4. Kaplan NM. Maximally reducing cardiovascular risk in the treatment of hypertension. Ann Intern Med. 1988;109:36-40.
FREE FULL TEXT
5. Moser M, Blaufox MD, Freis E, et al. Who really determines your patients' prescriptions? JAMA. 1991;265:498-500.
FREE FULL TEXT
6. Pollare T, Lithell H, Berne C. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med. 1989;321:868-873.
PUBMED
7. Bostick RM, Luepker RV, Kofron PM, Pirie PL. Changes in physician practice for the prevention of cardiovascular disease. Arch Intern Med. 1991;151:478-484.
FREE FULL TEXT
8. Leon M; Weisfeld V, ed. Updated Report on Access to Health Care in the United States: Results of a 1986 Survey. Princeton, NJ: The Robert Wood Johnson Foundation; 1987. 9. Shulman NB, Martinez B, Brogan D, Carr AA, Miles CG. Financial costs as an obstacle to hypertension therapy. Am J Public Health. 1986;76:1105-1108.
PUBMED
10. Roccella EJ. Cost of hypertension medications: is it a barrier to hypertension control? Geriatrics. 1989;44(suppl B):49-55.
PUBMED
11. Stason WB, Shephard DC, Perry HM Jr, Carmen BM, Nagurney JT, Mayer G. Effectiveness and costs of treating hypertension in VA clinics. J Hypertens. 1986;4(suppl 15):5395-5396.
12. Hypertension prevalence and the status of awareness, treatment, and control in the United States: final report of the Subcommittee on Definition and Prevalence of the 1984 Joint National Committee. Hypertension. 1985;7:457-468.
FREE FULL TEXT
13. 1988 Joint National Committee. The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1988;148:1023-1038.
FREE FULL TEXT
14. Joint National Committee. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1993;153:154-183.
FREE FULL TEXT
15. Zoler ML. Antihypertensives: a surfeit of choices. Med World News. October 1991:26-32. 16. Edelson JT, Weinstein MC, Tosteson ANA, Williams L, Lee TH, Goldman L. Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension. JAMA. 1990;263:408-413.
17. Black HR. Treatment of mild hypertension. JAMA. 1993;270:757-759.
FREE FULL TEXT
18. Neaton JD, Grimm RH, Prineas RJ, et al. Treatment of mild hypertension study. JAMA. 1993;270:713-724.
FREE FULL TEXT
19. Materson BJ, Reda DJ, Cushman WC, et al. Single drug therapy for hypertension in men. N Engl J Med. 1993;328:914-921.
PUBMED
|
